60 related articles for article (PubMed ID: 26603342)
1. Early Cardiovascular Disease After the Diagnosis of Systemic Sclerosis.
Aviña-Zubieta JA; Man A; Yurkovich M; Huang K; Sayre EC; Choi HK
Am J Med; 2016 Mar; 129(3):324-31. PubMed ID: 26603342
[TBL] [Abstract][Full Text] [Related]
2. Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
Gallacher PJ; Yeung D; Bell S; Shah ASV; Mills NL; Dhaun N
Eur Heart J; 2024 Apr; 45(15):1339-1351. PubMed ID: 38426727
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis and risk of bronchiectasis: a nationwide longitudinal cohort study.
Yang B; Kim BG; Han K; Jung JH; Kim JH; Park DW; Kim SH; Kim EG; Sohn JW; Yoon HJ; Choi H; Lee H
Arthritis Res Ther; 2023 Oct; 25(1):209. PubMed ID: 37872606
[TBL] [Abstract][Full Text] [Related]
4. Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke.
Fuglsang CH; Pedersen L; Schmidt M; Vandenbroucke JP; Bøtker HE; Sørensen HT
Neurology; 2024 Jan; 102(1):e207813. PubMed ID: 38165376
[TBL] [Abstract][Full Text] [Related]
5. The Brazilian Family Health Program and secondary stroke and myocardial infarction prevention: a 6-year cohort study.
Cabral NL; Franco S; Longo A; Moro C; Buss TA; Collares D; Werlich R; Dadan DD; Fissmer CS; Aragão A; Ferst P; Palharini FG; Eluf-Neto J; Fonseca LA; Whiteley WN; Gonçalves AR
Am J Public Health; 2012 Dec; 102(12):e90-5. PubMed ID: 23078478
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis is a risk factor of incident psoriasis: results from a nationwide cohort study.
Kwon OC; Han K; Park MC
Front Immunol; 2023; 14():1326298. PubMed ID: 38155970
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of myocardial infarction in amyotrophic lateral sclerosis: A nationwide cohort study in South Korea.
Kwon S; Kim B; Han KD; Jung W; Cho EB; Yang JH; Shin DW; Min JH
J Neurol Sci; 2023 Nov; 454():120829. PubMed ID: 37832380
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980-2016).
Coffey CM; Sandhu AS; Crowson CS; Achenbach SJ; Matteson EL; Osborn TG; Warrington KJ; Makol A
J Rheumatol; 2021 Jun; 48(6):877-882. PubMed ID: 33191288
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of cardiovascular disease in Japan: An overview study.
Ohira T; Eguchi E; Hayashi F; Kinuta M; Imano H
J Cardiol; 2024 Mar; 83(3):191-200. PubMed ID: 37591340
[TBL] [Abstract][Full Text] [Related]
10. Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer.
Rautiola J; Björklund J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjövall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Ann Surg Oncol; 2024 Mar; 31(3):1739-1748. PubMed ID: 38091152
[TBL] [Abstract][Full Text] [Related]
11. Preventing cardiovascular complications of acute infection: a missed opportunity?
Walkey AJ
Circulation; 2014 Apr; 129(13):1375-7. PubMed ID: 24523432
[No Abstract] [Full Text] [Related]
12. Living with Systemic Sclerosis: A Patient and Physician Perspective.
Young A; Rudy B; Volkmann ER
Rheumatol Ther; 2023 Aug; 10(4):785-792. PubMed ID: 37173569
[TBL] [Abstract][Full Text] [Related]
13. Biology and bias: do we have the will to improve cardiovascular disease outcomes for women?
Wei J; Henry TD; Bairey Merz CN
Heart; 2019 Apr; 105(7):503-505. PubMed ID: 30470724
[No Abstract] [Full Text] [Related]
14. Comment on: The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study.
Chen FY; Huo AP; Wei JC
Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38262345
[No Abstract] [Full Text] [Related]
15. Comment on: The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study. Reply.
Yen TH; Chen HH
Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38244564
[No Abstract] [Full Text] [Related]
16. Does a history of smoking increase the risk of developing systemic sclerosis? Insights from the Leiden Combined Care in Systemic Sclerosis cohort.
Ciaffi J; Liem SIE; Cannegieter SC; Ahmed S; Hoekstra E; Huizinga T; De Vries-Bouwstra J
Rheumatol Adv Pract; 2024; 8(2):rkae055. PubMed ID: 38736463
[No Abstract] [Full Text] [Related]
17. A prediction model for progressive disease in systemic sclerosis.
Meijs J; Schouffoer AA; Ajmone Marsan N; Stijnen T; Putter H; Ninaber MK; Huizinga TW; de Vries-Bouwstra JK
RMD Open; 2015; 1(1):e000113. PubMed ID: 26688749
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with Bosentan and Sildenafil improves Raynaud's phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis.
Bellando-Randone S; Lepri G; Bruni C; Blagojevic J; Radicati A; Cometi L; De Paulis A; Matucci-Cerinic M; Guiducci S
Clin Rheumatol; 2016 Jan; 35(1):127-32. PubMed ID: 26631100
[TBL] [Abstract][Full Text] [Related]
19. Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis.
Chen IW; Wang WT; Lai YC; Lin CM; Liu PH; Wu SZ; Hung KC
Sci Rep; 2024 Mar; 14(1):6445. PubMed ID: 38499699
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
